High expression of GST-π is known to accelerate the transformation and metabolism of anti-tumor drugs, shorten the duration of effective drug concentrations in cells and rapidly reduce the accumulation of drugs in target sites, thus reducing efficacy [42]. This evidence concerns the gene GSTP1 and neoplasm.